Sort   by:  
 Page size 
UnknownMechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer.
Not available
S-EPMC9538591 | biostudies-literature
UnknownInterim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.
Not available
S-EPMC10696466 | biostudies-literature
UnknownBroad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine.
Not available
S-EPMC10159263 | biostudies-literature
UnknownEffect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
Not available
S-EPMC4882617 | biostudies-literature
UnknownThe impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum.
Not available
S-EPMC4846810 | biostudies-literature
UnknownCommon Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
Not available
S-EPMC6312181 | biostudies-literature
Unknown2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Not available
S-EPMC10718225 | biostudies-literature
UnknownTrial of Solanezumab in Preclinical Alzheimer's Disease.
Not available
S-EPMC10559996 | biostudies-literature
UnknownPlasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status.
Not available
S-EPMC8590691 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
Sort   by:  
 Page size